We analyzed cancer-specific biclusters and found that the PI3K/Akt signaling pathway is strongly enriched with targets of a few miRNAs in breast cancer and diffuse large B-cell lymphoma. The gene discussed is AKT1; the disease is diffuse large B-cell lymphoma.